arBtrage CAPITALIZING MARKETS checking… Sign in

Achieve Life Sciences, Inc.

ACHV Health Care Biotechnology: In Vitro & In Vivo Diagnostic Substances
$5.13
▼ -3.0% Today
as of Jun 7, 07:08 ET
Last 30 days +20.14% Apr 28 → Jun 05
$4.00 $4.54 $5.07 $5.60 $6.14 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$5.23
High
$5.28
Low
$5.00
Volume
$766,165
Avg Vol
$1M
Mkt Cap
$544M
P/E (TTM)
Beta
52w High
$6.15
52w Low
$2.00
Div Yield
Shares Out
$53M

Overview

52-week range
$2.00
$6.15
75% of range
Avg surprise (last 2)
+18.3%
Avg reaction (last 2)
+7.0%
100% positive
Latest IV / EM
127%
EM ±17.5% · $5 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.43$-0.37$-0.31$-0.25$-0.19 Actual $-0.43Actual $-0.34Actual $-0.26Actual $-0.25Actual $-0.36Actual $-0.37Est $-0.37Actual $-0.37Actual $-0.28Actual $-0.19Est $-0.30 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-14M$-13M$-12M$-10M$-9M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue May 12, 2026Mar/2026 $-0.19 $-0.30 +36.7% +48.6% +7.2% earnings
Tue Sep 30, 2025Sep 2025 $-0.28 financials
Mon Jun 30, 2025Jun 2025 $-0.37 financials
Tue May 13, 2025Mar/2025 $-0.37 $-0.37 0.0% +6.9% earnings
Mon Sep 30, 2024Sep 2024 $-0.36 financials
Sun Jun 30, 2024Jun 2024 $-0.25 financials
Sun Mar 31, 2024Mar 2024 $-0.26 financials
Sat Sep 30, 2023Sep 2023 $-0.34 financials
Fri Jun 30, 2023Jun 2023 $-0.43 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue
Gross profit
Operating income
Net income$-10M$-14M$-13M$-13M$-13M$-8M
EPS (diluted)$-0.19$-0.28$-0.37$-0.37$-0.36$-0.25

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$28M$21M$32M$52M$13M$13M$10M$15M
Inventory
Total current assets$31M$40M$50M$57M$25M$36M$46M$63M
Total assets$33M$42M$52M$59M$27M$39M$48M$65M
Long-term debt
Total liabilities$22M$20M$18M$17M$17M$18M$17M$23M
Total equity$11M$22M$34M$42M$10M$21M$31M$42M

Implied volatility — last 90 days

121%124%126%129%131% Jun 07 — IV 127% · EM ±17.5%

Sector peers